Cell and Organ Transplantology. 2024; 12(1):38-43
DOI: 10.22494/cot.v12i1.161
Levels of melatonin and some indicators of angiogenesis, antioxidant system and lipid peroxidation in blood plasma in women with uterine leiomyoma
Sokolov В.1
, Berbets А.1, Shashi Kant2, Yuzko О.1
- 1Bukovinian State Medical University, Chernivtsi, Ukraine
- 2Patna Medical College and Hospital, Patna, India
Abstract
Uterine leiomyoma is one of the most common gynaecological diseases, which often leads to loss of fertility. It is known that in this pathology, damage to the tissues of the uterus is accompanied by oxidative stress, and the mechanisms of its compensation play a decisive role in the process of myometrial regeneration, especially when performing organ-preserving operations.
The aim of the study was to determine the levels of melatonin, reproductive hormones and state of angiogenesis, antioxidant system and lipid peroxidation in women of reproductive age who were diagnosed with uterine leiomyoma.
Material and methods. 60 women of reproductive age with uterine leiomyoma (study group) were examined. The control group consisted of 20 healthy women of the same age group. Melatonin levels in women’s blood were determined once, on an empty stomach, at 8 a.m.; the concentrations of estradiol and progesterone in the follicular phase of the menstrual cycle were also measured. The state of the angiogenesis system was studied by examining the levels of vascular endothelial growth factor (VEGF) and the content of the final metabolites of nitric oxide NO in blood plasma. The activity of the antioxidant system was assessed by blood plasma concentrations of reduced glutathione, glutathione peroxidase, and glutathione transferase. Indicators of lipid peroxidation were investigated by the content of malondialdehyde (MDA) in blood plasma and erythrocytes.
Results. It was found that in the patients of the study group with leiomyoma, there was a significantly lower level of melatonin in blood plasma (111.1 ± 18.5 ng/mL) compared to the control group (153.5 ± 8.5 ng/mL), while the concentration of estradiol was almost three times higher (107.4 ± 25.3 pg/mL) compared to the control group (36.2 ± 3.2 pg/mL), and the concentration of progesterone was 1.9 times higher (2.1 ± 0.4 ng/mL compared to 1.1 ± 0.5 ng/mL in the control group).
The level of VEGF in blood plasma in women with uterine leiomyoma was also higher (90.4 ± 23.6 pg/mL) compared to the control group (35.1 ± 8.3 pg/mL), as well as the concentration of final metabolites of nitric oxide, which reached 25.3 ± 5.9 pg/mL compared to 9.9 ± 3.9 pg/mL in the control group.
The reduced glutathione level in the blood plasma of women with uterine leiomyoma was significantly lower (0.77 ± 0.13 µmol/L) compared to healthy women (1.02 ± 0.14 µmol/L) in the control group, while the concentrations of glutathione-S-transferase and glutathione peroxidase enzymes were higher (161.3 ± 22.3 ng/mL and 235.7 ± 35.9 ng/mL, respectively), whereas in the control group these indicators were 118.9 ± 18.0 ng/mL and 105.3 ± 41.2 ng/mL, respectively. The MDA content in women of the study group was higher, measuring 5.2 ± 0.8 nmol/L in plasma and 10.8 ± 1.1 nmol/L in erythrocytes compared to 2.3 ± 0.8 nmol/L and 5.3 ± 0.8 nmol/L in the control group, respectively.
Conclusions. The levels of melatonin and reduced glutathione in the blood plasma of women with uterine leiomyoma were significantly lower, while the concentrations of estradiol, progesterone, glutathione-S-transferase, glutathione peroxidase, VEGF, final metabolites of nitric oxide, as well as the average MDA content in plasma and erythrocytes, were significantly higher compared to healthy women. In the study group, the relationship between the level of progesterone in blood plasma and the content of malondialdehyde in erythrocytes was described using a linear regression equation, which, as we suggest, indicates an activating effect of progesterone on oxidative stress mechanisms in the myometrium. In our opinion, oxidative stress in uterine leiomyoma occurs due to inadequate activity of the antioxidant system, an integral part of which is melatonin, leading to enhanced angiogenesis against the background of estrogen-induced myometrial proliferation.
Keywords: uterine leiomyoma; melatonin; estradiol; progesterone; vascular endothelial growth factor (VEGF); malondialdehyde (MDA); oxidative stress
Full Text PDF
| 1. Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol. 2003; 188(1):100-107. Available from: https://doi.org/10.1067/mob.2003.99 https://doi.org/10.1067/mob.2003.99 PMid:12548202 |
||||
| 2. Jayes FL, Liu B, Feng L, Aviles-Espinoza N, Leikin S, Leppert PC. Evidence of biomechanical and collagen heterogeneity in uterine fibroids. PLoS One. 2019; 14(4): e0215646. Available from: https://doi.org/10.1371/journal.pone.0215646 https://doi.org/10.1371/journal.pone.0215646 PMid:31034494 PMCid:PMC6488189 |
||||
| 3. Barjon K, Mikhail LN. Uterine Leiomyomata. [Updated 2023 Aug 7]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: Available from: https://www.ncbi.nlm.nih.gov/books/NBK546680/ | ||||
| 4. Ali M, Ciebiera M, Vafaei S, Alkhrait S, Chen HY, Chiang YF, et al. Progesterone Signaling and Uterine Fibroid Pathogenesis; Molecular Mechanisms and Potential Therapeutics. Cells. 2023; 12(8):1117. Available from: https://doi.org/10.3390/cells12081117 https://doi.org/10.3390/cells12081117 PMid:37190026 PMCid:PMC10136461 |
||||
| 5. Ono M, Qiang W, Serna VA, et al. Role of stem cells in human uterine leiomyoma growth. PLoS One. 2012; 7(5):e36935. Available from: https://doi.org/10.1371/journal.pone.0036935 https://doi.org/10.1371/journal.pone.0036935 PMid:22570742 PMCid:PMC3343011 |
||||
| 6. Liu S, Yin P, Kujawa SA, Coon JS, Okeigwe I, Bulun SE. Progesterone receptor integrates the effects of mutated MED12 and altered DNA methylation to stimulate RANKL expression and stem cell proliferation in uterine leiomyoma. Oncogene. 2019; 38(15):2722-2735. Available from: https://doi.org/10.1038/s41388-018-0612-6 https://doi.org/10.1038/s41388-018-0612-6 PMid:30538295 PMCid:PMC6461478 |
||||
| 7. Lv M, Yu J, Huang Y, Ma J, Xiang J, Wang Y, et al. Androgen Signaling in Uterine Diseases: New Insights and New Targets. Biomolecules. 2022; 12(11):1624. Available from: https://doi.org/10.3390/biom12111624 https://doi.org/10.3390/biom12111624 PMid:36358974 PMCid:PMC9687413 |
||||
| 8. Ciebiera M, Włodarczyk M, Zgliczyńska M, Łukaszuk K, Męczekalski B, Kobierzycki C, et al. The Role of Tumor Necrosis Factor α in the Biology of Uterine Fibroids and the Related Symptoms. Int J Mol Sci. 2018; 19(12):3869. Available from: https://doi.org/10.3390/ijms19123869 https://doi.org/10.3390/ijms19123869 PMid:30518097 PMCid:PMC6321234 |
||||
| 9. Xu X, Kim JJ, Li Y, Xie J, Shao C, Wei JJ. Oxidative stress-induced miRNAs modulate AKT signaling and promote cellular senescence in uterine leiomyoma. J Mol Med (Berl). 2018; 96(10):1095-1106. Available from: https://doi.org/10.1007/s00109-018-1682-1 https://doi.org/10.1007/s00109-018-1682-1 PMid:30097674 PMCid:PMC6135677 |
||||
| 10. Lin LC, Chang HY, Kuo TT, et al. Oxidative stress mediates the inhibitory effects of Manzamine A on uterine leiomyoma cell proliferation and extracellular matrix deposition via SOAT inhibition. Redox Biol. 2023; 66:102861. Available from: https://doi.org/10.1016/j.redox.2023.102861 https://doi.org/10.1016/j.redox.2023.102861 PMid:37666118 PMCid:PMC10491796 |
||||
| 11. Miyashita-Ishiwata M, El Sabeh M, Reschke LD, Afrin S, Borahay MA. Hypoxia induces proliferation via NOX4-Mediated oxidative stress and TGF-β3 signaling in uterine leiomyoma cells. Free Radic Res. 2022; 56(2):163-172. Available from: https://doi.org/10.1080/10715762.2022.2061967 https://doi.org/10.1080/10715762.2022.2061967 PMid:35377824 PMCid:PMC9863770 |
||||
| 12. Machado-Lopez A, Simón C, Mas A. Molecular and Cellular Insights into the Development of Uterine Fibroids. Int J Mol Sci. 2021; 22(16):8483. Available from: https://doi.org/10.3390/ijms22168483 https://doi.org/10.3390/ijms22168483 PMid:34445194 PMCid:PMC8395213 |
||||
| 13. Kurutas EB. The importance of antioxidants which play the role in cellular response against oxidative/nitrosative stress: current state. Nutr J. 2016; 15(1):71. Available from: https://doi.org/10.1186/s12937-016-0186-5 https://doi.org/10.1186/s12937-016-0186-5 PMid:27456681 PMCid:PMC4960740 |
||||
| 14. AlAshqar A, Lulseged B, Mason-Otey A, et al. Oxidative Stress and Antioxidants in Uterine Fibroids: Pathophysiology and Clinical Implications. Antioxidants (Basel). 2023; 12(4):807. Available from: https://doi.org/10.3390/antiox12040807 https://doi.org/10.3390/antiox12040807 PMid:37107181 PMCid:PMC10135366 |
||||
| 15. Park JY, Chae B, Kim MR. The Potential of Transforming Growth Factor-beta Inhibitor and Vascular Endothelial Growth Factor Inhibitor as Therapeutic Agents for Uterine Leiomyoma. Int J Med Sci. 2022; 19(12):1779-1786. Available from: https://doi.org/10.7150/ijms.75203 https://doi.org/10.7150/ijms.75203 PMid:36313223 PMCid:PMC9608041 |
||||
| 16. Don EE, Middelkoop MA, Hehenkamp WJK, Mijatovic V, Griffioen AW, Huirne JAF. Endometrial Angiogenesis of Abnormal Uterine Bleeding and Infertility in Patients with Uterine Fibroids-A Systematic Review. Int J Mol Sci. 2023; 24(8):7011. Available from: https://doi.org/10.3390/ijms24087011 https://doi.org/10.3390/ijms24087011 PMid:37108180 PMCid:PMC10138959 |
||||
| 17. Governini L, Marrocco C, Semplici B, Pavone V, Belmonte G, Luisi S, et al. Extracellular matrix remodeling and inflammatory pathway in human endometrium: insights from uterine leiomyomas. Fertil Steril. 2021; 116(5):1404-1414. Available from: https://doi.org/10.1016/j.fertnstert.2021.06.023 https://doi.org/10.1016/j.fertnstert.2021.06.023 PMid:34256950 |
||||
| 18. Middelkoop MA, Don EE, Hehenkamp WJK, Polman NJ, Griffioen AW, Huirne JAF. Angiogenesis in abnormal uterine bleeding: a narrative review. Hum Reprod Update. 2023; 29(4):457-485. Available from: https://doi.org/10.1093/humupd/dmad004 https://doi.org/10.1093/humupd/dmad004 PMid:36857162 PMCid:PMC10320491 |
||||
| 19. Lin LW, Wang SW, Huang WC, Huynh TK, Lai CY, Ko CY, et al. Melatonin Inhibits VEGF-Induced Endothelial Progenitor Cell Angiogenesis in Neovascular Age-Related Macular Degeneration. Cells. 2023; 12(5):799. Available from: https://doi.org/10.3390/cells12050799 https://doi.org/10.3390/cells12050799 PMid:36899935 PMCid:PMC10000467 |
||||
| 20. Shen C, Li Y, Chen Y, Huang L, Zhang F, Wu W. Melatonin prevents the binding of vascular endothelial growth factor to its receptor and promotes the expression of extracellular matrix-associated genes in nucleus pulposus cells. Exp Ther Med. 2020; 20(5):106. Available from: https://doi.org/10.3892/etm.2020.9227 https://doi.org/10.3892/etm.2020.9227 PMid:32989385 PMCid:PMC7517348 |
||||
| 21. Cheng J, Yang HL, Gu CJ, Liu YK, Shao J, Zhu R, et al. Melatonin restricts the viability and angiogenesis of vascular endothelial cells by suppressing HIF-1α/ROS/VEGF. Int J Mol Med. 2019; 43(2):945-955. Available from: https://doi.org/10.3892/ijmm.2018.4021 https://doi.org/10.3892/ijmm.2018.4021 |
||||
| 22. Lin PH, Tung YT, Chen HY, Chiang YF, Hong HC, Huang KC, et al. Melatonin activates cell death programs for the suppression of uterine leiomyoma cell proliferation. J Pineal Res. 2020; 68(1):e12620. Available from: https://doi.org/10.1111/jpi.12620 https://doi.org/10.1111/jpi.12620 PMid:31710386 |
||||
| 23. Tejchman K, Kotfis K, Sieńko J. Biomarkers and Mechanisms of Oxidative Stress-Last 20 Years of Research with an Emphasis on Kidney Damage and Renal Transplantation. Int J Mol Sci. 2021; 22(15):8010. Available from: https://doi.org/10.3390/ijms22158010 https://doi.org/10.3390/ijms22158010 PMid:34360776 PMCid:PMC8347360 |
||||
| 24. Zitkute V, Kvietkauskas M, Leber B, Strupas K, Stiegler P, Schemmer P. Ischemia and reperfusion injury in uterus transplantation: A comprehensive review, Transplantation Reviews. 2020; 34(3): 100550. Available from: https://doi.org/10.1016/j.trre.2020.100550 https://doi.org/10.1016/j.trre.2020.100550 PMid:32498979 |
||||
| 25. Santulli P, Borghese B, Lemaréchal H, Leconte M, Millischer A-E, Batteux F, et al. Increased Serum Oxidative Stress Markers in Women with Uterine Leiomyoma. PLoS ONE. 2013; 8(8): e72069. Available from: https://doi.org/10.1371/journal.pone.0072069 https://doi.org/10.1371/journal.pone.0072069 PMid:23951284 PMCid:PMC3739822 |
||||
| 26. Ugurlu T, Ozogul C, Saribas GS, Gurgen SG, Akyol SN, Kartal B. The effect of antioxidants on angiogenesis in uterine transplantation. Journal of Obstetrics and Gynaecology. 2018; 38(3): 382-387. Available from: https://doi.org/10.1080/01443615.2017.1316250 https://doi.org/10.1080/01443615.2017.1316250 PMid:29385880 |
||||
| 27. Tschudi MR, Mesaros S, Lüscher TF, Malinski T. Direct in situ measurement of nitric oxide in mesenteric resistance arteries. Increased decomposition by superoxide in hypertension. Hypertension. 1996; 27(1):32-35. Available from: https://doi.org/10.1161/01.hyp.27.1.32 https://doi.org/10.1161/01.HYP.27.1.32 PMid:8591884 |
||||
| 28. Travina OV. Guide to biochemical research. Moscow: Medgiz, 1955. P. 250-255. [In Russian] | ||||
| 29. Fletcher NM, Saed MG, Abu-Soud HM, Al-Hendy A, Diamond MP, Saed GM. Uterine fibroids are characterized by an impaired antioxidant cellular system: Potential role of hypoxia in the pathophysiology of uterine fibroids. J. Assist. Reprod. Genet. 2013; 30:969-974. Available from: https://doi.org/10.1007/s10815-013-0029-7 https://doi.org/10.1007/s10815-013-0029-7 PMid:23812845 PMCid:PMC3725220 |
||||
| 30. Miyashita-Ishiwata M, El Sabeh M, Reschke LD, Afrin S, Borahay MA. Hypoxia induces proliferation via NOX4-Mediated oxidative stress and TGF-beta3 signaling in uterine leiomyoma cells. Free Radic Res. 2022; 56:163-172. Available from: https://doi.org/10.1080/10715762.2022.2061967 https://doi.org/10.1080/10715762.2022.2061967 PMid:35377824 PMCid:PMC9863770 |
||||
| 31. Maghraby N, El Noweihi AM, El-Melegy NT, Mostafa NAM, Abbas AM, El-Deek HEM, et al. Increased Expression of Fibroblast Activation Protein is Associated with Autophagy Dysregulation and Oxidative Stress in Obese Women with Uterine Fibroids. Reprod. Sci. 2022; 29:448-459. Available from: https://doi.org/10.1007/s43032-021-00810-0 https://doi.org/10.1007/s43032-021-00810-0 PMid:34845667 |
||||
| 32. Li Y, Xu X, Asif H, Feng Y, Kohrn BF, Kennedy SR, et al. Myometrial oxidative stress drives MED12 mutations in leiomyoma. Cell Biosci. 2022; 12:111. Available from: https://doi.org/10.1186/s13578-022-00852-0 https://doi.org/10.1186/s13578-022-00852-0 PMid:35869560 PMCid:PMC9308324 |
||||
| 33. Xu X, Kim JJ, Li Y, Xie J, Shao C, Wei JJ. Oxidative stress-induced miRNAs modulate AKT signaling and promote cellular senescence in uterine leiomyoma. J Mol Med. 2018; 96:1095-1106. Available from: https://doi.org/10.1007/s00109-018-1682-1 https://doi.org/10.1007/s00109-018-1682-1 PMid:30097674 PMCid:PMC6135677 |
||||
| 34. Nasiadek M, Krawczyk T, Sapota A. Tissue levels of cadmium and trace elements in patients with myoma and uterine cancer. Hum. Exp. Toxicol. 2005; 24:623-630. Available from: https://doi.org/10.1191/0960327105ht575oa https://doi.org/10.1191/0960327105ht575oa PMid:16408615 |
||||
| 35. Kurjak A, Kupesic-Urek S, Miric D. The assessment of benign uterine tumor vascularization by transvaginal color Doppler. Ultrasound Med. Biol. 1992; 18:645-649. Available from: https://doi.org/10.1016/0301-5629(92)90079-P https://doi.org/10.1016/0301-5629(92)90079-P PMid:1413276 |
||||
| 36. Uluer ET, Inan S, Ozbilgin K, Karaca F, Dicle N, Sanci M. The role of hypoxia related angiogenesis in uterine smooth muscle tumors. Biotech Histochem. 2015; 90:102-110. Available from: https://doi.org/10.3109/10520295.2014.952339 https://doi.org/10.3109/10520295.2014.952339 PMid:25225843 |
||||
| 37. Miyashita-Ishiwata M, El Sabeh M, Reschke LD, Afrin S, Borahay MA. Differential response to hypoxia in leiomyoma and myometrial cells. Life Sci. 2022; 290:120238. Available from: https://doi.org/10.1016/j.lfs.2021.120238 https://doi.org/10.1016/j.lfs.2021.120238 PMid:34942165 PMCid:PMC8757389 |
||||
| 38. El Sabeh M, Afrin S, Singh B, et al. Uterine Stem Cells and Benign Gynecological Disorders: Role in Pathobiology and Therapeutic Implications. Stem Cell Rev Rep. 2021; 17:803-820. Available from: https://doi.org/10.1007/s12015-020-10075-w https://doi.org/10.1007/s12015-020-10075-w PMid:33155150 PMCid:PMC8096869 |
||||
| 39. Chang, HL, Senaratne TN, Zhang L, Szotek PP, Stewart E, Dombkowski D, et al. Uterine leiomyomas exhibit fewer stem/progenitor cell characteristics when compared with corresponding normal myometrium. Reprod Sci. 2010; 17(2):158-167. Available from: https://doi.org/10.1177/1933719109348924 https://doi.org/10.1177/1933719109348924 PMid:19805552 PMCid:PMC2818305 |
||||
| 40. McGuire MM, Yatsenko A, Hoffner L, Jones M, Surti U, Rajkovic A. Whole exome sequencing in a random sample of North American women with leiomyomas identifies MED12 mutations in majority of uterine leiomyomas. PLoS One. 2012; 7(3):e33251. Available from: https://doi.org/10.1371/journal.pone.0033251 https://doi.org/10.1371/journal.pone.0033251 PMid:22428002 PMCid:PMC3299761 |
||||
| 41. Mohyeldin A, Garzon-Muvdi T, Quinones-Hinojosa A. Oxygen in stem cell biology: A critical component of the stem cell niche. Cell Stem Cell. 2010; 7(2):150-161. Available from: https://doi.org/10.1016/j.stem.2010.07.007 https://doi.org/10.1016/j.stem.2010.07.007 PMid:20682444 |
||||
| 42. Toprani SM, Kelkar Mane V. Role of DNA damage and repair mechanisms in uterine fibroid/leiomyomas: A review. Biol. Reprod. 2021; 104:58-70. Available from: https://doi.org/10.1093/biolre/ioaa157 https://doi.org/10.1093/biolre/ioaa157 PMid:32902600 |
||||
Sokolov В, Berbets А, Shashi Kant Yadav, Yuzko О. Levels of melatonin and some indicators of angiogenesis, antioxidant system and lipid peroxidation in blood plasma in women with uterine leiomyoma. Cell Organ Transpl. 2024; 12(1):38-43. Available from: https://doi.org/10.22494/cot.v12i1.161
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.